|
NCT00002396
|
|
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
|
Phase 1
|
Active, Not Recruiting
|
|
NCT00121017
|
|
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects
|
Phase 2
|
Withdrawn
|
|
NCT00002450
|
|
Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
|
Phase 3
|
Completed
|
|
NCT00002415
|
|
Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
|
Phase 2
|
Completed
|
|
NCT00007436
|
|
The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00122512
|
|
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
|
Phase 2
|
Terminated
|
|
NCT01634386
|
|
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fasting Conditions
|
Phase 1
|
Completed
|
|
NCT01634399
|
|
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions
|
Phase 1
|
Completed
|
|
NCT01634373
|
|
Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets
|
Phase 1
|
Completed
|
|
NCT01815723
|
2015-06-01 |
Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
|
Phase 3
|
Not Yet Recruiting
|
|
NCT01528865
|
2015-04-01 |
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
|
Phase 1/Phase 2
|
Not Yet Recruiting
|
|
NCT02351908
|
2015-02-01 |
Renal Integrase Study
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02337426
|
2015-02-01 |
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
Phase 1
|
Recruiting
|
|
NCT02343159
|
2015-02-01 |
Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02308319
|
2015-01-01 |
Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02195518
|
2014-12-01 |
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02268396
|
2014-11-01 |
Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD
|
Phase 3
|
Active, Not Recruiting
|
|
NCT02243735
|
2014-11-01 |
Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02206555
|
2014-11-01 |
PrEP Demonstration Project (PRELUDE Study)
|
Phase 4
|
Recruiting
|
|
NCT02271997
|
2014-10-01 |
Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass
|
Phase 4
|
Enrolling By Invitation
|
|
NCT02224456
|
2014-10-01 |
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02196077
|
2014-08-01 |
Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2
|
Active, Not Recruiting
|
|
NCT02283853
|
2014-08-01 |
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
|
Phase 3
|
Recruiting
|
|
NCT02228902
|
2014-08-01 |
Iron Absorption Trial
|
Phase 4
|
Enrolling By Invitation
|
|
NCT02196714
|
2014-07-01 |
PK Study of PT003 and PT001 in Japanese Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT01853787
|
2014-07-01 |
Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study
|
Phase 4
|
Recruiting
|
|
NCT02171208
|
2014-06-01 |
A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
|
Phase 1
|
Completed
|
|
NCT02062463
|
2014-06-01 |
Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma
|
Phase 4
|
Active, Not Recruiting
|
|
NCT02125604
|
2014-06-01 |
Gastrointestinal Tolerability Study Of Dimethyl Fumarate (DMF) In Participants With Relapsing-Remitting Multiple Sclerosis In Germany
|
Phase 4
|
Recruiting
|
|
NCT02090413
|
2014-05-01 |
Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate (DMF)-Treated Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
|
Phase 4
|
Recruiting
|
|
NCT02090348
|
2014-05-01 |
Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With BG00012 or Standard of Care
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02148120
|
2014-04-01 |
A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler
|
Phase 2
|
Completed
|
|
NCT02087631
|
2014-04-01 |
Safety and Tolerability of Quetiapine in Multiple Sclerosis
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT02128971
|
2014-04-01 |
A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo
|
Phase 2
|
Recruiting
|
|
NCT02097849
|
2014-03-01 |
A Phase 3b Study of BG00012's Effect on Vaccination Response in Subjects With Relapsed Forms of Multiple Sclerosis
|
Phase 3
|
Not Yet Recruiting
|
|
NCT01658891
|
2014-02-01 |
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
|
Phase 3
|
Withdrawn
|
|
NCT01949467
|
2014-02-01 |
Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
|
Phase 2
|
Recruiting
|
|
NCT02005588
|
2013-12-01 |
Treatment of Iron Deficiency Anemia With Pregnancy
|
Phase 0
|
Recruiting
|
|
NCT01996124
|
2013-11-01 |
Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients
|
Phase 4
|
Completed
|
|
NCT01975272
|
2013-11-01 |
The Use of Iron Therapy for Patients With Anemia After Surgery
|
Phase 4
|
Not Yet Recruiting
|
|
NCT01953107
|
2013-11-01 |
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
|
Phase 4
|
Recruiting
|
|
NCT01930708
|
2013-10-01 |
A Study Evaluating the Effectiveness of Tecfidera™ (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes
|
Phase 4
|
Recruiting
|
|
NCT01709084
|
2013-10-01 |
A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01908140
|
2013-09-01 |
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3
|
Completed
|
|
NCT01940471
|
2013-09-01 |
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01924832
|
2013-08-01 |
BG00012 Regional Absorption Study
|
Phase 1
|
Completed
|
|
NCT01915901
|
2013-08-01 |
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
|
Phase 1
|
Completed
|
|
NCT01632891
|
2013-07-01 |
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT01858948
|
2013-07-01 |
SGA-induced Metabolic Syndrome in Bipolar Youth
|
Phase 3
|
Recruiting
|
|
NCT01687218
|
2013-06-01 |
Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
|
Phase 2
|
Recruiting
|
|
NCT01838668
|
2013-03-01 |
An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
|
Phase 3
|
Recruiting
|
|
NCT01840605
|
2013-03-01 |
A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis
|
Phase 3
|
Completed
|
|
NCT01777997
|
2013-02-01 |
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01745822
|
2013-01-01 |
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
|
Phase 3
|
Recruiting
|
|
NCT01762995
|
2012-12-01 |
A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects
|
Phase 1
|
Completed
|
|
NCT01656434
|
2012-11-01 |
Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
|
Phase 3
|
Terminated
|
|
NCT01641367
|
2012-10-01 |
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
|
Phase 4
|
Recruiting
|
|
NCT01491295
|
2012-09-01 |
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
|
Phase 4
|
Recruiting
|
|
NCT01741623
|
2012-08-01 |
Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition
|
Phase 1
|
Completed
|
|
NCT01744873
|
2012-08-01 |
Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition
|
Phase 1
|
Completed
|
|
NCT01605890
|
2012-07-01 |
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
|
Phase 2
|
Recruiting
|
|
NCT01605617
|
2012-06-01 |
Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
|
Phase 4
|
Terminated
|
|
NCT01641081
|
2012-06-01 |
Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
|
Phase 2
|
Completed
|
|
NCT01505114
|
2012-06-01 |
Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01592305
|
2012-05-01 |
A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir
|
Phase 1
|
Completed
|
|
NCT01566760
|
2012-05-01 |
A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT01650441
|
2012-04-01 |
Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01568112
|
2012-04-01 |
A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events
|
Phase 3
|
Completed
|
|
NCT01572792
|
2012-04-01 |
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3
|
Completed
|
|
NCT01189318
|
2012-03-01 |
Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
|
Phase 2
|
Recruiting
|
|
NCT01712854
|
2012-03-01 |
Investigating the Effects of Symbicort on the Ventilatory Kinematics in Patients With Obstructive Disease With Optoelectronic Plethysmography
|
Phase 4
|
Terminated
|
|
NCT01566149
|
2012-03-01 |
Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)
|
Phase 3
|
Completed
|
|
NCT01671787
|
2012-03-01 |
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B
|
Phase 1
|
Completed
|
|
NCT01448616
|
2012-02-01 |
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01803087
|
2012-02-01 |
Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
|
Phase 2
|
Completed
|
|
NCT01522625
|
2012-01-01 |
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
|
Phase 4
|
Recruiting
|
|
NCT01352715
|
2012-01-01 |
Study of Options for Second-Line Effective Combination Therapy (SELECT)
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01400412
|
2011-12-01 |
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
|
Phase 2
|
Completed
|
|
NCT01515813
|
2011-11-01 |
Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
|
Phase 2
|
Withdrawn
|
|
NCT01462942
|
2011-10-01 |
Long-term Efficacy and Safety of Aclidinium/Formoterol Fixed-Dose Combination
|
Phase 3
|
Completed
|
|
NCT01352117
|
2011-10-01 |
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
|
Phase 3
|
Recruiting
|
|
NCT01437540
|
2011-09-01 |
Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 3
|
Completed
|
|
NCT01437397
|
2011-09-01 |
Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3
|
Completed
|
|
NCT01475032
|
2011-09-01 |
"Efficacy Study of the Product ""CHF 1535"" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children"
|
Phase 3
|
Completed
|
|
NCT01450774
|
2011-09-01 |
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
|
Phase 3
|
Completed
|
|
NCT01327651
|
2011-08-01 |
The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
|
Phase 2
|
Completed
|
|
NCT01352988
|
2011-07-01 |
Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
|
Phase 2
|
Completed
|
|
NCT01349868
|
2011-05-01 |
PT005 MDI Dose Ranging Versus Foradil Aerolizer Study
|
Phase 2
|
Completed
|
|
NCT01349803
|
2011-05-01 |
PT003 MDI Cardiovascular Safety Study
|
Phase 2
|
Completed
|
|
NCT01321164
|
2011-04-01 |
Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis
|
Phase 3
|
Completed
|
|
NCT01603173
|
2011-04-01 |
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
|
Phase 1
|
Completed
|
|
NCT01326858
|
2011-04-01 |
Safety and Comfort of AL-4943A Ophthalmic Solution
|
Phase 1
|
Completed
|
|
NCT01155375
|
2011-04-01 |
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01603186
|
2011-04-01 |
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
|
Phase 1
|
Completed
|
|
NCT01066858
|
2011-03-01 |
Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01379508
|
2011-03-01 |
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
|
Phase 4
|
Recruiting
|
|
NCT01300234
|
2011-03-01 |
Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01234116
|
2011-02-01 |
Post-Exposure Prophylaxis in Health Care Workers
|
Phase 4
|
Completed
|
|
NCT01281111
|
2011-02-01 |
Alternate Dosing Regimens of BG00012 in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00799864
|
2011-01-01 |
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01285050
|
2011-01-01 |
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
|
Phase 4
|
Recruiting
|
|
NCT01258803
|
2010-12-01 |
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)
|
Phase 2
|
Completed
|
|
NCT01256177
|
2010-12-01 |
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
|
Phase 3
|
Completed
|
|
NCT01254721
|
2010-12-01 |
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
|
Phase 4
|
Terminated
|
|
NCT01213836
|
2010-11-01 |
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia
|
Phase 4
|
Completed
|
|
NCT01322451
|
2010-11-01 |
Oral Bioavailability of Two Solid Formulations of GLPG0259.
|
Phase 1
|
Completed
|
|
NCT01165541
|
2010-09-01 |
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2
|
Completed
|
|
NCT01168310
|
2010-08-01 |
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2
|
Completed
|
|
NCT01587066
|
2010-08-01 |
Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
|
Phase 4
|
Withdrawn
|
|
NCT01043601
|
2010-07-01 |
Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control
|
Phase 2
|
Withdrawn
|
|
NCT01566487
|
2010-06-01 |
Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition
|
Phase 1
|
Completed
|
|
NCT01128114
|
2010-06-01 |
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
|
Phase 4
|
Terminated
|
|
NCT01113593
|
2010-05-01 |
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
|
Phase 2
|
Completed
|
|
NCT01088165
|
2010-05-01 |
The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
|
Phase 4
|
Recruiting
|
|
NCT01156311
|
2010-05-01 |
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
|
Phase 2
|
Completed
|
|
NCT01085045
|
2010-03-01 |
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2
|
Completed
|
|
NCT01049360
|
2009-12-01 |
Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo
|
Phase 2
|
Completed
|
|
NCT01040091
|
2009-12-01 |
Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
|
Phase 1/Phase 2
|
Completed
|
|
NCT00929851
|
2009-10-01 |
BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)
|
Phase 3
|
Completed
|
|
NCT00995800
|
2009-10-01 |
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
|
Phase 2
|
Completed
|
|
NCT00705679
|
2009-08-01 |
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
|
Phase 2
|
Completed
|
|
NCT01033942
|
2009-08-01 |
Pre-Exposure Prophylaxis in YMSM
|
Phase 2
|
Completed
|
|
NCT00896051
|
2009-08-01 |
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
|
Phase 2
|
Completed
|
|
NCT00903084
|
2009-06-01 |
Examining Hair to Determine Tenofovir Exposure
|
Phase 1
|
Not Yet Recruiting
|
|
NCT00931723
|
2009-06-01 |
Adult Bipolar Mania
|
Phase 4
|
Completed
|
|
NCT00919607
|
2009-06-01 |
Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients
|
Phase 1
|
Completed
|
|
NCT00811954
|
2009-05-01 |
Comparative Study of Three NNRTI-Sparing HAART Regimens
|
Phase 3
|
Completed
|
|
NCT00882518
|
2009-04-01 |
Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
|
Phase 3
|
Completed
|
|
NCT00832650
|
2009-04-01 |
Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit
|
Phase 1
|
Terminated
|
|
NCT00883493
|
2009-04-01 |
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
|
Phase 3
|
Completed
|
|
NCT00852631
|
2009-02-01 |
Seroquel XR in Adults With Schizophrenia
|
Phase 3
|
Terminated
|
|
NCT00828789
|
2009-02-01 |
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
|
Phase 1
|
Completed
|
|
NCT00804622
|
2008-12-01 |
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
|
Phase 2
|
Completed
|
|
NCT00837343
|
2008-12-01 |
A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
|
Phase 4
|
Recruiting
|
|
NCT00774761
|
2008-11-01 |
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2
|
Completed
|
|
NCT00779506
|
2008-11-01 |
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
|
Phase 4
|
Completed
|
|
NCT00880490
|
2008-11-01 |
Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 1/Phase 2
|
Completed
|
|
NCT00734292
|
2008-09-01 |
Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma
|
Phase 2
|
Completed
|
|
NCT00734162
|
2008-09-01 |
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00746330
|
2008-08-01 |
Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma
|
Phase 2
|
Completed
|
|
NCT00838032
|
2008-08-01 |
Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia
|
Phase 4
|
Recruiting
|
|
NCT00736190
|
2008-08-01 |
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
|
Phase 4
|
Completed
|
|
NCT00711009
|
2008-07-01 |
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
|
Phase 3
|
Completed
|
|
NCT00724711
|
2008-07-01 |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
Phase 4
|
Completed
|
|
NCT00702676
|
2008-07-01 |
Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison
|
Phase 1
|
Completed
|
|
NCT00592124
|
2008-06-01 |
Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
|
Phase 2
|
Completed
|
|
NCT00706914
|
2008-06-01 |
Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2
|
Completed
|
|
NCT00798434
|
2008-06-01 |
A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.
|
Phase 4
|
Completed
|
|
NCT00647244
|
2008-06-01 |
Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
|
Phase 4
|
Completed
|
|
NCT00702325
|
2008-06-01 |
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
|
Phase 4
|
Completed
|
|
NCT00660972
|
2008-05-01 |
Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
|
Phase 1
|
Completed
|
|
NCT00557245
|
2008-05-01 |
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
|
Phase 3
|
Completed
|
|
NCT00672490
|
2008-04-01 |
Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder
|
Phase 4
|
Completed
|
|
NCT00633776
|
2008-03-01 |
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
|
Phase 4
|
Withdrawn
|
|
NCT00640601
|
2008-03-01 |
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
|
Phase 3
|
Completed
|
|
NCT00658684
|
2008-02-01 |
Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.
|
Phase 3
|
Completed
|
|
NCT00622245
|
2008-01-01 |
Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
|
Phase 2
|
Terminated
|
|
NCT00498628
|
2007-12-01 |
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
|
Phase 2
|
Completed
|
|
NCT00551018
|
2007-12-01 |
Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
|
Phase 2
|
Completed
|
|
NCT00561951
|
2007-11-01 |
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
|
Phase 2
|
Completed
|
|
NCT01074645
|
2007-11-01 |
Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure
|
Phase 4
|
Completed
|
|
NCT00534599
|
2007-08-01 |
Generalized Anxiety Disorder Adjunct Study
|
Phase 3
|
Completed
|
|
NCT00458393
|
2007-06-01 |
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00442962
|
2007-05-01 |
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
|
Phase 4
|
Completed
|
|
NCT01078818
|
2007-05-01 |
Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation
|
Phase 4
|
Completed
|
|
NCT00102206
|
2007-05-01 |
A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
|
Phase 2
|
Completed
|
|
NCT00476073
|
2007-04-01 |
Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma
|
Phase 3
|
Completed
|
|
NCT00444925
|
2007-04-01 |
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
|
Phase 3
|
Completed
|
|
NCT00370500
|
2007-04-01 |
Quetiapine and the Dopaminergic Epigenetic Control
|
Phase 4
|
Completed
|
|
NCT00675896
|
2007-04-01 |
A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome
|
Phase 4
|
Completed
|
|
NCT00475813
|
2007-03-01 |
Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma
|
Phase 3
|
Completed
|
|
NCT00507234
|
2007-03-01 |
Study in Subjects Greater Than 40 Years of Age With COPD
|
Phase 3
|
Completed
|
|
NCT00448669
|
2007-03-01 |
Botswana TDF/FTC Oral HIV Prophylaxis Trial
|
Phase 2/Phase 3
|
Completed
|
|
NCT00953134
|
2007-02-01 |
Periconceptional Iron Supplementation in Rural Bangladesh
|
Phase 0
|
Completed
|
|
NCT00426023
|
2007-02-01 |
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
|
Phase 3
|
Completed
|
|
NCT00569712
|
2007-01-01 |
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
|
Phase 1
|
Completed
|
|
NCT00422123
|
2007-01-01 |
Phase 3 /Seroquel SR Acute Mania Monotherapy - US
|
Phase 3
|
Completed
|
|
NCT00425100
|
2007-01-01 |
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
|
Phase 3
|
Completed
|
|
NCT00428350
|
2006-12-01 |
Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
|
Phase 4
|
Completed
|
|
NCT00422214
|
2006-12-01 |
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
|
Phase 3
|
Completed
|
|
NCT00120471
|
2006-11-01 |
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
|
Phase 1
|
Completed
|
|
NCT00403286
|
2006-11-01 |
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2
|
Completed
|
|
NCT00089505
|
2006-11-01 |
NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission
|
Phase 3
|
Completed
|
|
NCT00418509
|
2006-11-01 |
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00383240
|
2006-09-01 |
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)
|
Phase 3
|
Completed
|
|
NCT00383552
|
2006-09-01 |
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)
|
Phase 3
|
Completed
|
|
NCT00648817
|
2006-07-01 |
Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
|
Phase 4
|
Completed
|
|
NCT00393991
|
2006-07-01 |
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
|
Phase 3
|
Completed
|
|
NCT00393952
|
2006-06-01 |
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
|
Phase 3
|
Completed
|
|
NCT00394199
|
2006-06-01 |
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
|
Phase 3
|
Completed
|
|
NCT00322595
|
2006-05-01 |
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
|
Phase 3
|
Completed
|
|
NCT00326105
|
2006-04-01 |
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
|
Phase 3
|
Completed
|
|
NCT00329264
|
2006-04-01 |
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
|
Phase 3
|
Completed
|
|
NCT00320268
|
2006-04-01 |
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00308191
|
2006-04-01 |
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
|
Phase 3
|
Completed
|
|
NCT00215449
|
2006-04-01 |
Study in Patients With COPD
|
Phase 3
|
Completed
|
|
NCT00545558
|
2006-04-01 |
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
|
Phase 1
|
Completed
|
|
NCT00298363
|
2006-04-01 |
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.
|
Phase 2
|
Completed
|
|
NCT00326144
|
2006-04-01 |
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
|
Phase 3
|
Completed
|
|
NCT00329446
|
2006-04-01 |
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
|
Phase 3
|
Completed
|
|
NCT00321490
|
2006-04-01 |
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00099632
|
2006-03-01 |
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
|
Phase 2
|
Completed
|
|
NCT00394121
|
2006-03-01 |
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
|
Phase 3
|
Completed
|
|
NCT00050895
|
2006-03-01 |
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
|
Phase 3
|
Completed
|
|
NCT00733668
|
2006-03-01 |
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
|
Phase 2
|
Completed
|
|
NCT00260078
|
2006-02-01 |
Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children
|
Phase 1/Phase 2
|
Completed
|
|
NCT00280371
|
2006-01-01 |
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
|
Phase 3
|
Completed
|
|
NCT00114686
|
2006-01-01 |
Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
|
Phase 3
|
Completed
|
|
NCT00280358
|
2005-12-01 |
A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.
|
Phase 1
|
Completed
|
|
NCT00278941
|
2005-12-01 |
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00215397
|
2005-12-01 |
Study in Patients With Asthma
|
Phase 2
|
Completed
|
|
NCT00215410
|
2005-10-01 |
Study in Patients With Asthma
|
Phase 2
|
Completed
|
|
NCT00215384
|
2005-10-01 |
Study in Patients With COPD
|
Phase 2
|
Completed
|
|
NCT00255515
|
2005-09-01 |
Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia
|
Phase 4
|
Completed
|
|
NCT00139932
|
2005-09-01 |
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED)
|
Phase 4
|
Completed
|
|
NCT00215423
|
2005-09-01 |
Study in Patients With COPD
|
Phase 2
|
Completed
|
|
NCT00118898
|
2005-09-01 |
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
|
Phase 3
|
Completed
|
|
NCT00111150
|
2005-09-01 |
Botswana Tenofovir Oral HIV Prophylaxis Trial
|
Phase 2/Phase 3
|
Terminated
|
|
NCT00356616
|
2005-09-01 |
Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
|
Phase 4
|
Terminated
|
|
NCT00206141
|
2005-08-01 |
Seroquel in Bipolar Depression Versus Lithium
|
Phase 3
|
Completed
|
|
NCT00448578
|
2005-08-01 |
Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients
|
Phase 3
|
Completed
|
|
NCT00139074
|
2005-07-01 |
Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
|
Phase 4
|
Terminated
|
|
NCT00254787
|
2005-06-01 |
Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients
|
Phase 2
|
Completed
|
|
NCT00027339
|
2005-06-01 |
Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
|
Phase 2
|
Completed
|
|
NCT00116805
|
2005-06-01 |
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00122070
|
2005-05-01 |
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
|
Phase 3
|
Completed
|
|
NCT00033163
|
2005-05-01 |
A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV
|
Phase 2
|
Completed
|
|
NCT00084136
|
2005-05-01 |
Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
|
Phase 4
|
Completed
|
|
NCT00119652
|
2005-05-01 |
Seroquel in Bipolar Depression Versus SSRI
|
Phase 3
|
Completed
|
|
NCT00119379
|
2005-04-01 |
Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults
|
Phase 2
|
Completed
|
|
NCT00105079
|
2005-04-01 |
GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection
|
Phase 3
|
Completed
|
|
NCT00136266
|
2005-03-01 |
Adherence With Iron Sprinkles Among High-Risk Infants
|
Phase 3
|
Completed
|
|
NCT00314184
|
2005-03-01 |
Quetiapine Fumarate Bipolar Maintenance Monotherapy
|
Phase 3
|
Completed
|
|
NCT00215436
|
2005-03-01 |
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
|
Phase 3
|
Completed
|
|
NCT00074581
|
2005-02-01 |
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00131677
|
2005-02-01 |
Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men
|
Phase 2
|
Completed
|
|
NCT00090779
|
2005-01-01 |
Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
|
Phase 2
|
Terminated
|
|
NCT00306540
|
2004-12-01 |
Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
|
Phase 3
|
Completed
|
|
NCT00394368
|
2004-11-01 |
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
|
Phase 3
|
Completed
|
|
NCT00830102
|
2004-10-01 |
Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients
|
Phase 2
|
Completed
|
|
NCT00413387
|
2004-09-01 |
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
|
Phase 3
|
Completed
|
|
NCT00090324
|
2004-09-01 |
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
|
Phase 3
|
Completed
|
|
NCT00227305
|
2004-08-01 |
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
|
Phase 3
|
Completed
|
|
NCT00304473
|
2004-08-01 |
Fast Titration in the Treatment of Schizophrenia, Taiwan
|
Phase 3
|
Completed
|
|
NCT00090311
|
2004-07-01 |
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
|
Phase 3
|
Completed
|
|
NCT00122486
|
2004-07-01 |
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
|
Phase 2
|
Completed
|
|
NCT00083954
|
2004-06-01 |
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
|
Phase 3
|
Completed
|
|
NCT00085891
|
2004-06-01 |
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
|
Phase 3
|
Completed
|
|
NCT00254748
|
2004-06-01 |
Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients
|
Phase 2
|
Completed
|
|
NCT00107731
|
2004-04-01 |
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
|
Phase 3
|
Completed
|
|
NCT00081380
|
2004-03-01 |
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
|
Phase 3
|
Completed
|
|
NCT00076791
|
2004-03-01 |
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
|
Phase 1
|
Completed
|
|
NCT00229645
|
2003-11-01 |
A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety
|
Phase 4
|
Completed
|
|
NCT00867867
|
2003-10-01 |
Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries
|
Phase 1
|
Completed
|
|
NCT00206102
|
2003-09-01 |
A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
|
Phase 4
|
Completed
|
|
NCT00112047
|
2003-07-01 |
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
|
Phase 3
|
Completed
|
|
NCT00449397
|
2003-07-01 |
Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
|
Phase 3
|
Completed
|
|
NCT00046033
|
2003-03-01 |
Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
|
Phase 2
|
Completed
|
|
NCT00055120
|
2003-03-01 |
When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
|
Phase 4
|
Completed
|
|
NCT00270556
|
2003-01-01 |
Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.
|
Phase 2
|
Completed
|
|
NCT00621647
|
2002-09-01 |
Seroquel- Agitation Associated With Dementia
|
Phase 3
|
Completed
|
|
NCT00060489
|
2002-09-01 |
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
|
Phase 3
|
Completed
|
|
NCT00215358
|
2002-07-01 |
Study in Patients With Asthma
|
Phase 2
|
Completed
|
|
NCT00215371
|
2002-07-01 |
Study in Patients With Asthma
|
Phase 2
|
Completed
|
|
NCT02251145
|
2002-05-01 |
Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00254735
|
2002-04-01 |
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
|
Phase 3
|
Completed
|
|
NCT00254774
|
2002-01-01 |
Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling
|
Phase 3
|
Completed
|
|
NCT00305422
|
2001-11-01 |
Effect of Quetiapine on Negative Symptoms and Cognition
|
Phase 3
|
Completed
|
|
NCT00034905
|
2001-07-01 |
A Comparison of Seroquel vs. Risperidone in Schizophrenia
|
Phase 4
|
Completed
|
|
NCT02182557
|
2001-06-01 |
WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients
|
Phase 3
|
Completed
|
|
NCT02182544
|
2001-06-01 |
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis
|
Phase 3
|
Completed
|
|
NCT00158821
|
2000-03-01 |
Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
|
Phase 3
|
Completed
|
|
NCT00004886
|
1999-12-01 |
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
|
Phase 1
|
Completed
|
|
NCT00000296
|
1997-11-01 |
Role of Metabolites in Nicotine Dependence (4) - 13
|
Phase 2
|
Completed
|
|
NCT00000288
|
1995-12-01 |
Role of Metabolites in Nicotine Dependence (2) - 5
|
Phase 2
|
Completed
|
|
NCT00000284
|
1995-02-01 |
Role of Metabolites in Nicotine Dependence (1) - 1
|
Phase 2
|
Completed
|
|
NCT00913549
|
1989-12-01 |
To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
|
Phase 1
|
Completed
|